(Q42986473)

12 November 2017

0 references

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

2

P Boffetta

1 reference

12 November 2017

F Donato

1

1 reference

PubMed ID

9455792

12 November 2017

M Puoti

series ordinal

3

1 reference

PubMed ID

9455792

12 November 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

International Journal of Cancer

12 November 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 November 2017

75

1 reference

12 November 2017

3

1 reference

12 November 2017

347-354

1 reference

Clearance of HBsAg in seven patients with chronic hepatitis B

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

International collaborative study on the second EUROHEP HCV-RNA reference panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Dominant replication of either virus in dual infection with hepatitis viruses B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B and C virus serologies among Japanese Americans with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Clinical and virological profiles in patients with multiple hepatitis virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Case-control study of hepatocellular carcinoma among Koreans living in Osaka, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Genetic heterogeneity of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

High prevalence of hepatitis C in Egyptian patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Reliability of polymerase chain reaction for detection of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980130%2975%3A3%3C347%3A%3AAID-IJC4%3E3.0.CO%3B2-2

10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

9455792